Palatin Technologies, Inc. (AMEX:PTN)
CAPS Rating:
A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.
RSS Headlines
Fool UK